Related Experiment Videos

Detection of beta-lactamase production and enzyme profiles in Enterobacteriaceae isolated in Moldova

A Poiată1, R Gheorghiu, D Diculencu

  • 1Departament of Microbiology, University of Medicine and Pharmacy, Iaşi.

Insights

Sixteen Enterobacteriaceae strains exhibited resistance to ampicillin-sulbactam and amoxycillin-clavulanic acid. The study characterized novel plasmid-encoded beta-lactamases in Salmonella strains, resistant to these antibiotics.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Antibiotic resistance is a growing global health concern.
  • Beta-lactam antibiotics, including penicillins and cephalosporins, are widely used.
  • Emergence of beta-lactamases poses a significant threat to antibiotic efficacy.

Purpose of the Study:

  • To characterize the beta-lactamase activity of Enterobacteriaceae strains resistant to ampicillin-sulbactam and amoxycillin-clavulanic acid.
  • To identify the genetic basis and enzyme class of these novel beta-lactamases.

Main Methods:

  • Isolation and identification of Enterobacteriaceae strains.
  • Antimicrobial susceptibility testing against beta-lactam antibiotics and their inhibitors.
  • Enzymatic assays using Sarcina lutea and enzymatic filtrates.
  • Determination of beta-lactamase enzyme types based on antibiotic inactivation profiles.
  • Plasmid analysis to determine genetic linkage.

Main Results:

  • Sixteen out of 449 Enterobacteriaceae strains showed resistance to both ampicillin-sulbactam and amoxycillin-clavulanic acid.
  • The resistant strains produced beta-lactamases that inactivated penicillins and cephalosporins, except carbenicillin and oxacillin.
  • These novel beta-lactamases were resistant to sulbactam and clavulanic acid.
  • In Salmonella strains, the beta-lactamases were plasmid-encoded.

Conclusions:

  • A new class of plasmid-encoded beta-lactamases conferring resistance to beta-lactamase inhibitors has emerged in Enterobacteriaceae.
  • These findings highlight the need for continuous surveillance of antibiotic resistance mechanisms.
  • Further research is warranted to understand the prevalence and clinical implications of these novel enzymes.

Related Concept Videos